Sitagliptin for Prevention of aGVHD After Alternative Donor Transplatation
Conditions: Acute-graft-versus-host Disease; Allogeneic Hematopoietic Stem Cell Transplantation Interventions: Drug: Sitagliptin + Standard Prophylaxis; Drug: Standard Prophylaxis Sponsors: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital with Nanjing Medical University; The Second People's Hospital of Huai'an; The First People's Hospital of Changzhou; Xinqiao Hospital of Chongqing Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials